Use of direct oral anticoagulants as primary or secondary prophylaxis of venous thromboembolism in patients with multiple myeloma on immunomodulatory drugs (Record no. 72022)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00601cam a2200193 4500 |
| 001 - CONTROL NUMBER | |
| control field | CN99462 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120401t2020 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 25729241 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Aguilar C.; Duenas A.; Sevil F.; Dominguez C.; Cam |
| 240 ## - UNIFORM TITLE | |
| Uniform title | <a href="HemaSphere">HemaSphere</a> |
| 245 ## - TITLE STATEMENT | |
| Title | Use of direct oral anticoagulants as primary or secondary prophylaxis of venous thromboembolism in patients with multiple myeloma on immunomodulatory drugs |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 948 |
| 500 ## - GENERAL NOTE | |
| General note | Serial |
| 500 ## - GENERAL NOTE | |
| General note | 7156066 |
| 500 ## - GENERAL NOTE | |
| General note | 4 |
| 500 ## - GENERAL NOTE | |
| General note | https://doi.org/ |
| 500 ## - GENERAL NOTE | |
| General note | Document_7156066_49994.pdf |
No items available.
London Health Libraries Consortium Privacy notice and Membership terms and conditions